Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systemic Lupus Erythematosus, Thrombotic Microangiopathy, and Purtscher-Like Retinopathy in a Patient Who Experienced Resolution With Eculizumab Treatment: A Case Report.
Baltacı MA, Temiz Gençoğlu AT, Karakulak MB, Erol YÖ, Keleşoğlu Dinçer AB. Baltacı MA, et al. Among authors: erol yo. HSS J. 2024 Nov 26:15563316241300474. doi: 10.1177/15563316241300474. Online ahead of print. HSS J. 2024. PMID: 39605987 Free PMC article. No abstract available.
Real Life Multicenter Comparison of 24-Month Outcomes of Anti-VEGF Therapy in Diabetic Macular Edema in Turkey: Ranibizumab vs. Aflibercept vs. Ranibizumab-Aflibercept Switch.
Kucukevcilioglu M, Yeşiltaş YS, Durukan AH, Unlu N, Onen M, Alp MN, Kalayci D, Acar MA, Sekeroglu MA, Citirik M, Altintas AGK, Hazirolan D, Ozdal PC, Toklu Y, Bicer T, Ugurlu N, Budakoglu O, Yazar Z, Zeki NIU, Serdar K, Doguizi S, Erol YO, Atilgan CU, Yorgun MA, Soba DO, Berker N, Baskan C. Kucukevcilioglu M, et al. Among authors: erol yo. Medicina (Kaunas). 2023 Jan 30;59(2):263. doi: 10.3390/medicina59020263. Medicina (Kaunas). 2023. PMID: 36837465 Free PMC article.
Anti-vascular endothelial growth factor therapy in diabetic macular edema: real-life outcomes from a multicenter study in Turkey over 36 months.
Durukan AH, Unlu N, Onen M, Alp MN, Yeşiltaş YS, Kalayci D, Acar MA, Sekeroglu MA, Citirik M, Altintas AGK, Hazirolan D, Kucukevcilioglu M, Ozdal PC, Toklu Y, Bicer T, Ugurlu N, Budakoglu O, Yazar Z, Ucgun NI, Serdar K, Doguizi S, Erol YO, Atilgan CU, Yorgun MA, Soba DO, Berker N, Baskan C, Yilmaz ES. Durukan AH, et al. Among authors: erol yo. Int Ophthalmol. 2022 Dec;42(12):3777-3787. doi: 10.1007/s10792-022-02375-6. Epub 2022 Jul 13. Int Ophthalmol. 2022. PMID: 35829865
The status of the choroid in patients with optic disc drusen.
Gediz BS, Erol YO, Gungor A, Ilhan B. Gediz BS, et al. Among authors: erol yo. Int Ophthalmol. 2022 Dec;42(12):3891-3896. doi: 10.1007/s10792-022-02409-z. Epub 2022 Jul 4. Int Ophthalmol. 2022. PMID: 35788860
29 results